Kermit L. Carraway

21.3k total citations · 6 hit papers
272 papers, 17.1k citations indexed

About

Kermit L. Carraway is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Kermit L. Carraway has authored 272 papers receiving a total of 17.1k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Molecular Biology, 88 papers in Cell Biology and 75 papers in Oncology. Recurrent topics in Kermit L. Carraway's work include Glycosylation and Glycoproteins Research (110 papers), Monoclonal and Polyclonal Antibodies Research (64 papers) and HER2/EGFR in Cancer Research (54 papers). Kermit L. Carraway is often cited by papers focused on Glycosylation and Glycoproteins Research (110 papers), Monoclonal and Polyclonal Antibodies Research (64 papers) and HER2/EGFR in Cancer Research (54 papers). Kermit L. Carraway collaborates with scholars based in United States, France and United Kingdom. Kermit L. Carraway's co-authors include Lewis C. Cantley, Coralie A. Carothers Carraway, Colleen Sweeney, Daniel E. Koshland, Richard A. Cerione, Masanobu Komatsu, Pamela M. Guy, Bak C. Shin, Richard B. Triplett and Nevis Fregien and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kermit L. Carraway

271 papers receiving 16.4k citations

Hit Papers

Catalytic specificity of protein-tyrosine kinases... 1972 2026 1990 2008 1995 1996 1994 1994 1994 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
    1995 805 citations Kermit L. Carraway et al. profile →
  2. Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
    1996 562 citations Kermit L. Carraway et al. profile →
  3. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
    1994 560 citations Kermit L. Carraway et al. Journal of Biological Chemistry profile →
  4. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
    1994 553 citations Pamela M. Guy, Kermit L. Carraway et al. profile →
  5. A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
    1994 516 citations Kermit L. Carraway et al. profile →
  6. [56] Carbodiimide modification of proteins
    1972 343 citations Kermit L. Carraway et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kermit L. Carraway United States 67 11.2k 5.9k 3.8k 2.8k 2.3k 272 17.1k
David Givol Israel 77 12.4k 1.1× 5.0k 0.8× 2.8k 0.7× 2.0k 0.7× 2.6k 1.2× 262 18.0k
Graham Carpenter United States 60 7.5k 0.7× 3.8k 0.7× 2.2k 0.6× 2.0k 0.7× 1.2k 0.5× 120 11.7k
Reiji Kannagi Japan 66 11.1k 1.0× 1.9k 0.3× 2.6k 0.7× 2.9k 1.0× 4.5k 2.0× 303 15.0k
A. Ullrich Germany 92 22.5k 2.0× 9.0k 1.5× 4.9k 1.3× 3.8k 1.3× 4.3k 1.9× 193 33.0k
Pier Giorgio Natali Italy 61 5.3k 0.5× 3.1k 0.5× 1.7k 0.5× 1.2k 0.4× 2.6k 1.2× 260 11.3k
Steven T. Pals Netherlands 71 9.6k 0.9× 5.0k 0.9× 1.3k 0.3× 3.1k 1.1× 6.2k 2.7× 238 20.9k
Lewis T. Williams United States 65 15.2k 1.4× 4.1k 0.7× 1.1k 0.3× 3.5k 1.2× 4.6k 2.0× 114 22.0k
Paul Polakis United States 64 17.8k 1.6× 4.9k 0.8× 1.4k 0.4× 3.1k 1.1× 1.3k 0.6× 118 21.9k
William J. Muller Canada 80 13.3k 1.2× 9.2k 1.6× 1.9k 0.5× 2.8k 1.0× 3.4k 1.5× 267 21.2k
David F. Stern United States 64 7.6k 0.7× 5.8k 1.0× 2.9k 0.7× 1.5k 0.5× 1.0k 0.5× 140 12.6k

Countries citing papers authored by Kermit L. Carraway

Since Specialization
Citations

This map shows the geographic impact of Kermit L. Carraway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kermit L. Carraway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kermit L. Carraway more than expected).

Fields of papers citing papers by Kermit L. Carraway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kermit L. Carraway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kermit L. Carraway. The network helps show where Kermit L. Carraway may publish in the future.

Co-authorship network of co-authors of Kermit L. Carraway

This figure shows the co-authorship network connecting the top 25 collaborators of Kermit L. Carraway. A scholar is included among the top collaborators of Kermit L. Carraway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kermit L. Carraway. Kermit L. Carraway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simion, Catalina, Neelu Batra, Anastasia L. Berg, et al.. (2019). A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells. Cancer Research. 80(3). 418–429. 49 indexed citations
2.
Fiehn, Oliver, Nicole Perfito, Kermit L. Carraway, et al.. (2013). Study 16: Replication of Ward et al., 2010 (Cancer Cell). OSF Preprints (OSF Preprints). 2 indexed citations
3.
Krig, Sheryl R., Seth Frietze, Catalina Simion, et al.. (2011). Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ERα-Positive Breast Cancer. Molecular Cancer Research. 9(10). 1406–1417. 54 indexed citations
4.
Albrecht, Huguette & Kermit L. Carraway. (2011). MUC1 and MUC4: Switching the Emphasis from Large to Small. Cancer Biotherapy and Radiopharmaceuticals. 26(3). 261–271. 37 indexed citations
5.
Carraway, Coralie A. Carothers, et al.. (2010). Mechanistic and signaling analysis of Muc4–ErbB2 signaling module: New insights into the mechanism of ligand‐independent ErbB2 activity. Journal of Cellular Physiology. 224(3). 649–657. 17 indexed citations
6.
Siddiqui, Salma, Swagata Bose, Benjamin A. Mooso, et al.. (2010). Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells. Cancer Research. 70(14). 5994–6003. 48 indexed citations
7.
Workman, Heather C., Colleen Sweeney, & Kermit L. Carraway. (2009). The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms. Cancer Research. 69(7). 2845–2852. 60 indexed citations
8.
Shattuck, David L., Jamie K. Miller, Kermit L. Carraway, & Colleen Sweeney. (2008). Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells. Cancer Research. 68(5). 1471–1477. 344 indexed citations
9.
Lomako, Joseph, Wieslawa M. Lomako, C A Carraway, & Kermit L. Carraway. (2006). Post–Translation Regulation of Muc4 in Cultured Corneal Epithelium Cells by Proteolytic Degradation. Investigative Ophthalmology & Visual Science. 47(13). 1608–1608. 1 indexed citations
10.
Carraway, Kermit L. & Colleen Sweeney. (2006). Co-opted integrin signaling in ErbB2-induced mammary tumor progression. Cancer Cell. 10(2). 93–95. 21 indexed citations
11.
Palau, Victoria, et al.. (2006). Membrane Mucin Muc4 Induces Density-dependent Changes in ERK Activation in Mammary Epithelial and Tumor Cells. Journal of Biological Chemistry. 281(39). 29411–29420. 25 indexed citations
12.
Weed, Donald T., Carmen Gomez‐Fernandez, Jose Ruiz, et al.. (2004). MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma. Head & Neck. 26(4). 353–364. 44 indexed citations
13.
Weed, Donald T., Carmen Gomez‐Fernandez, Mohammed Yasin, et al.. (2004). MUC4 and ErbB2 Expression in Squamous Cell Carcinoma of the Upper Aerodigestive Tract: Correlation With Clinical Outcomes. The Laryngoscope. 114(S101). 1–32. 35 indexed citations
14.
Price‐Schiavi, Shari A., Eran R. Andrechek, Peter Li, et al.. (2004). Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy. Journal of Cellular Physiology. 203(1). 44–53. 23 indexed citations
15.
16.
Carraway, Kermit L., et al.. (2002). ErbB2 and Its Ligand Muc4 (Sialomucin Complex) in Rat Lacrimal Gland. Advances in experimental medicine and biology. 506(Pt A). 289–295. 32 indexed citations
17.
Carraway, Kermit L., Victoria Palau, Bushra Haq, & Coralie A. Carothers Carraway. (2002). Cell signaling through membrane mucins. BioEssays. 25(1). 66–71. 198 indexed citations
18.
Carraway, Coralie A. Carothers, et al.. (2001). Differential localization of ErbB2 in different tissues of the rat female reproductive tract: Implications for the use of specific antibodies for ErbB2 analysis. Journal of Cellular Physiology. 189(2). 162–170. 19 indexed citations
19.
Johnson, Eric F., et al.. (2000). Insights into the HER-2 Receptor Tyrosine Kinase Mechanism and Substrate Specificity Using a Transient Kinetic Analysis. Biochemistry. 39(32). 9786–9803. 20 indexed citations
20.
Carraway, Kermit L., Edmund A. Rossi, Masanobu Komatsu, et al.. (1999). An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling. Journal of Biological Chemistry. 274(9). 5263–5266. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Givol Breakdown of academic impact, for papers by Graham Carpenter Breakdown of academic impact, for papers by Reiji Kannagi Breakdown of academic impact, for papers by A. Ullrich Breakdown of academic impact, for papers by Pier Giorgio Natali Breakdown of academic impact, for papers by Steven T. Pals Breakdown of academic impact, for papers by Lewis T. Williams Breakdown of academic impact, for papers by Paul Polakis Breakdown of academic impact, for papers by William J. Muller Breakdown of academic impact, for papers by David F. Stern
Rankless by CCL
2026